Autosomal dominant optic atrophy and congenital deafness

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:3212OMIM:125250
Who is this for?
Show terms as
1Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Autosomal dominant optic atrophy and congenital deafness (also known as optic atrophy with hearing loss, or Konigsmark syndrome) is a rare genetic disorder characterized by the combination of progressive visual loss due to optic nerve atrophy and sensorineural hearing impairment that is present from birth or early childhood. The condition primarily affects two sensory systems: the visual system, through degeneration of the optic nerve leading to reduced visual acuity, color vision deficits, and visual field loss; and the auditory system, through sensorineural deafness that can range from moderate to severe. The optic atrophy typically manifests as pallor of the optic disc observed on fundoscopic examination, and visual deterioration may be progressive over time. This condition follows an autosomal dominant inheritance pattern, meaning that a single copy of the altered gene inherited from one affected parent is sufficient to cause the disorder. Each child of an affected individual has a 50% chance of inheriting the condition. The molecular genetic basis of this specific entity remains incompletely characterized, and it should be distinguished from other syndromic forms of optic atrophy such as Wolfram syndrome or the more common Kjer-type autosomal dominant optic atrophy (OPA1-related). There is currently no curative treatment available. Management is supportive and multidisciplinary, involving regular ophthalmologic monitoring, low-vision aids, hearing aids or cochlear implants for hearing rehabilitation, and genetic counseling for affected families.

Also known as:

Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Childhood

Begins in childhood, roughly ages 1 to 12

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Autosomal dominant optic atrophy and congenital deafness.

View clinical trials →

No actively recruiting trials found for Autosomal dominant optic atrophy and congenital deafness at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Autosomal dominant optic atrophy and congenital deafness community →

Specialists

1 foundView all specialists →
JM
Jeffrey Weiss, MD
Specialist
PI on 2 active trials

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Autosomal dominant optic atrophy and congenital deafness.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Autosomal dominant optic atrophy and congenital deafnessForum →

No community posts yet. Be the first to share your experience with Autosomal dominant optic atrophy and congenital deafness.

Start the conversation →

Latest news about Autosomal dominant optic atrophy and congenital deafness

No recent news articles for Autosomal dominant optic atrophy and congenital deafness.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Autosomal dominant optic atrophy and congenital deafness

What is Autosomal dominant optic atrophy and congenital deafness?

Autosomal dominant optic atrophy and congenital deafness (also known as optic atrophy with hearing loss, or Konigsmark syndrome) is a rare genetic disorder characterized by the combination of progressive visual loss due to optic nerve atrophy and sensorineural hearing impairment that is present from birth or early childhood. The condition primarily affects two sensory systems: the visual system, through degeneration of the optic nerve leading to reduced visual acuity, color vision deficits, and visual field loss; and the auditory system, through sensorineural deafness that can range from moder

How is Autosomal dominant optic atrophy and congenital deafness inherited?

Autosomal dominant optic atrophy and congenital deafness follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Autosomal dominant optic atrophy and congenital deafness typically begin?

Typical onset of Autosomal dominant optic atrophy and congenital deafness is childhood. Age of onset can vary across affected individuals.

Which specialists treat Autosomal dominant optic atrophy and congenital deafness?

1 specialists and care centers treating Autosomal dominant optic atrophy and congenital deafness are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.